Log in

Ancestim associated with Filgrastim and/or chemotherapy can improve blood progenitor yields in patients who previously failed mobilisation

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Da Silva MG, Pimentel P, Carvalhais A et al. Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilisation in patients with a prior insufficient PBPC collection. Bone Marrow Transplant 2004; 34: 683–691.

    Article  CAS  Google Scholar 

  2. To LB, Bashford J, Durrant S et al. Successful mobilisation of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilisation with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim. Bone Marrow Transplant 2003; 31: 371–378.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Appendix A

Appendix A

Participating centers

King's College Hospital, London (Professor GJ Mufti, Dr A Mijovic), Royal Marsden Hospital, London (Professor R Powles), Royal Free Hospital, London (Dr M Potter), Nottingham City Hospital (Professor N Russell), St James'Hospital, Dublin (Dr P Browne), St Vincent's Hospital, Dublin (Dr J Crown), Belfast City Hospital (Dr TCM Morris) and Royal Liverpool University Hospitals (Dr RE Clark).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mijovic, A., Russell, N., Clark, R. et al. Ancestim associated with Filgrastim and/or chemotherapy can improve blood progenitor yields in patients who previously failed mobilisation. Bone Marrow Transplant 35, 1019 (2005). https://doi.org/10.1038/sj.bmt.1704950

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704950

  • Springer Nature Limited

Navigation